Request Information

Premier Perspectives

The blog for insider insights in clinical development

Data Management & Biostatistics

Real-World Data and Real-World Evidence: What Is Their Value as a Synthetic Control Arm?

By

May 26, 2020

Featured Posts

Learn more about the latest events and updates.

COVID-19

PM360 – Leveraging Emergency Use Authorizations to Bring COVID-19 Products to Market

By

May 7, 2020

COVID-19

Data Driven: How Electronic Patient-Reported Outcomes (ePROs) Provide a Vital Opportunity to Capture Key Data Beyond the COVID-19 Crisis

By

April 30, 2020

Recent Posts

Learn more about the latest events and updates.

COVID-19

What Is FDA’s Emergency Use Authorization (EUA) and How Can It Help Develop Therapies Faster?

By

March 20, 2020

COVID-19

FDA Issues Guidance on Clinical Trials During COVID-19

By

March 20, 2020

Consulting

FAQ: How the EU Medical Devices Regulation Affects Existing Products

By

May 8, 2019

Medical and Regulatory Affairs

The Evolution of Regulations for Digital Health Products

By

November 5, 2018

Consulting

Sponsors and CROs get More Clarity on Precision, Targeted Therapy Trials

By

January 3, 2018

Consulting

Optimizing Regulatory Considerations for Orphan-Drug Development on a Global Scale

By

December 19, 2017